Global Gastric Volvulus Treatment Market – Industry Trends and Forecast to 2030

Global Gastric Volvulus Treatment Market, By Type (Organo-Axial Volvulus, Mesentero-Axial Volvulus), Treatment Type (Medication, Surgery), Drugs (Analgesics, Antiemetic Agents, Others), Route of Administration (Oral, Parenteral), End- User (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy) – Industry Trends and Forecast to 2030.

Gastric Volvulus Treatment Market Analysis and Size

Gastric volvulus is a rare syndrome that occurs in both adults and pediatric patients. In about 10% to 30% of cases, gastric volvulus is considered primary and results from laxity and disruption of the stomach's ligamentous attachments. Gastric volvulus occurs in children who are generally less than 1 year of age and in older adults, aged 50 years and above. The primary cause of a gastric volvulus in both children and adults is a paraesophageal hernia

Data Bridge Market Research analyses a growth rate in the gastric volvulus treatment market in the forecast period 2023-2030. The expected CAGR of gastric volvulus treatment market is tend to be around 4.6% in the mentioned forecast period. The market was valued at USD 25.8 billion in 2022, and it would grow up to USD 37 billion by 2030. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Gastric Volvulus Treatment Market Scope and Segmentation

Market Definition

Gastric volvulus is a heterogeneous group of volvulus which is known by its abnormal rotation of all or part of the stomach through more than 180°. The rotation could be either longitudinal or transverse. This condition is very rare and can cause a closed-loop obstruction or strangulation. It is more prevalent in children and elderly patients. Gastric volvulus may be present either acutely or with recurrent, intermittent, land chronic symptoms.

Gastric Volvulus Treatment Market Dynamics

Drivers

• Rising Cases of Gastric Volvulus

It has been witnessed that males and females are equally affected with this condition. Around 10-20% of cases occur in children, generally before the age of 1 year. This disease is more widespread in around 30 % of cases in old age. Therefore, this increasing incidence is demanding higher medications and thus boosting the market growth.

• Increased Diagnosis of Gastric volvulus

The diagnosis of a gastric volvulus can be diagnosed with a good history and physical exam; though, diagnosis can be difficult. The diagnosis of a gastric volvulus can be confirmed radiologically when patients are slightly symptomatic. Plain chest x-ray films are used to detect a spherical stomach or a double air-fluid level on upright chest films and the retrocardiac air-fluid level above the diaphragm on lateral chest film. Computed tomography (CT) scans of the chest, abdomen, and pelvis are also performed for the correct diagnosis. CT scan of the abdomen, chest, and pelvis can provide accurate information about the nature of volvulus, and other intraabdominal organs which may be involved, therefore assisting pre-operative planning. Therefore, it boost the market growth.

Opportunities

• Increasing Treatment Methods

The traditional treatment for patients suffering from gastric volvulus has been an immediate operation minimizing and untwisting the volvulus. This remains the gold standard; however, medical management may be very useful in patients with a very high risk for surgery. Surgical resection is also used for necrosis or perforation of the stomach. Laparoscopy is also performed to repair chronic and intermittent gastric volvulus. Percutaneous gastrostomy placement can be performed for ill patients having chronic or intermittent volvulus. Thus, all these treatment methods are boosting the growth of the market.

Restraints/Challenges

• High Cost of Treatment

The huge expenditure that is necessitated for the surgeries and different treatment processes inhibits market growth. Several market players make some immense investments in manufacturing new and advanced treatment procedures to surge the recovery process, and in return, the cost is increased.

This gastric volvulus treatment market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the gastric volvulus treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Gastric Volvulus Treatment Market Scope

The gastric volvulus treatment market is segmented on the basis of type, treatment type, drugs, route of administration, end user and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

• Organo-Axial Volvulus
• Mesentero-Axial Volvulus

Treatment Type

• Medication
• Surgery

Drugs

• Analgesics
• Antiemetic Agents
• Others

Route of Administration

• Oral
• Parenteral

End-User

• Hospitals
• Homecare
• Specialty Clinics
• Others

Distribution Channel

• Hospital Pharmacy
• Retail Pharmacy

Gastric Volvulus Treatment Regional Analysis/Insights

The gastric volvulus treatment market is analyzed and market size insights and trends are provided by type, treatment type, drugs, route of administration, end user and distribution channel as referenced above.

The major countries covered in the gastric volvulus treatment market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America is dominating the market in the forecast period because of the rise in the incidence of the disease, increase in the healthcare affordability in the U.S. and surge in the knowledge and awareness amongst the people in this region.

Asia-Pacific is considered to grow over the coming years because of the rise in the research & development and having strong government support in this region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data. 

Competitive Landscape and Global Gastric Volvulus Treatment Share Analysis

The gastric volvulus treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to gastric volvulus treatment market

Key players operating in the gastric volvulus treatment market include:

• Sawai Pharmaceutical Co.,Ltd (Japan)
• PAI Pharma (U.S.)
• Sun Pharmaceutical Industries Ltd (India)
• ANI Pharmaceuticals, Inc. (U.S.)
• Fresenius SE & Co. KGaA (Germany)
• Mayne Pharma Group Limited (Australia)
• Teva Pharmaceutical Industries Ltd (Israel)
• Glenmark Pharmaceuticals Ltd (India)
• Tris Pharma, Inc. (U.S.)
• Pfizer Inc (U.S.)
• Mallinckrodt (U.K.)
• Mylan N.V. (U.S.)
• GSK plc (U.K.)
• Par Pharmaceutical. (U.S.)
• Vintage Labs (India)
• Zydus Group (India)